Infection of several strains of laboratory mice with a virulent strain of Yersinia enterocolitica was followed by performing viable bacterial counts on homogenates of selected tissues at intervals after intragastric, aerogenic, or intravenous infection. It is observed that CD-1 mice are more susceptible to Y. enterocolitica infection than either the C57B1/6 or B6D2 strains. Development of an enteric infection is dose dependent; less than 5 x 107 organisms by mouth vields sporadic, low levels of systemic infection, with many of the animals showing no apparent infection. Increasing the challenge inoculum by a factor of 10 eliminates the variability among the animals, giving rise to an enteric infection in all of the mice that moves quickly to the mesenteric lymph node. The bacterial population in the lymph node multiplies rapidly, and the infection is disseminated to the spleen, liver, and lungs, ultimately killing most of the animals. Exposure to an aerogenic challenge of less than 1,000 organisms resulted in a fulminating pneumonitis with an invariably fatal outcome. Intravenous challenge with 500 organisms caused a rapidly fatal, systemic infection. The growth of the bacteria in the intravenously infected mouse depends upon the temperature at which the challenge inoculum had been grown in vitro. At temperatures below 26 C, the bacteria are cleared from the blood at a slower rate and are more resistant to intracellular killing, as compared to organisms grown at 37X C. This effect results in the inoculum increasing to greater numbers in the tissues in a shorter period of time.
Yersinia enterocolitica is being increasingly recognized as a probable cause of acute gastroenteritis in man (13, 15, 18) . Furthermore, such chronic, systemic diseases as Reiter syndrome, erythema nodosum, arthritis, oseitis, and others (15) may be sequelae to a primary Yersinia infection that may have been either severely debilitating or subclinical in nature. There is a large body of circumstantial evidence'that Y. enterocolitica is pathogenic for man (12) , but it has not been possible to confirm early reports (19) count, and the others were placed in a 37 C water bath shaker. At intervals, tubes were removed and chilled immediately in an ice-water bath, and the ratio of cell-associated to cell-free yersiniae was determined (1) .
RESULTS
Oral Y. enterocolitica WA infection. None of the mice was susceptible to intragastric infection with strain 5819, but is was possible to infect CD-1, C57B1/6, and B6D2 mice orally with 3 x 107 Y. enterocolitica WA, a dose equivalent to 0.1 mean lethal dose values (4). Severe systemic infections and death occurred in some of the animals, but many others demonstrated only minimal infections when tested at this dose level. The sporadic nature of the oral infection was overcome by increasing the challenge dose to 5 x 108 viable bacteria ( Table 1) . The Yersinia quickly infected the mesenteric lymph node, and the bacterial population progressively increased in numbers at that site. From the infectious foci in the mesenteric node, organisms spread to the spleen, liver, and lungs to varying degrees in different animals. Death occurred from day 4 onward, with peak mortality on day 8. The fact that yersiniae did not appear in the lung until after day 4 indicated that the lung was not directly infected during the intragastric challenge procedure (9) .
Because a number of animals succumbed to the infection between days 6 and 8, animals necropsied on days 8 (Fig. 1) . The viable counts for the liver and spleen decreased steadily, and the organisms were undetectable in vivo by 48 h. It was, however, possible to infect CD-1, C57B1, or B6D2 mice by this route using as few as 100 viable Y. enterocolitica WA. The lowest challenge doses gave rise to sporadic systemic infections with some mice developing large populations of Yersinia in their tissues, whereas others had very few. As was seen in the oral and aerogenic infections, the C57B1 and B6D2 mice contained fewer bacteria in their tissues than the CD-1 mice after the intravenous infection. The intravenous challenge of CD-1 mice with small doses of virulent yersiniae infected all of the mice; however, most of the organisms localized in the spleen. As the infection progressed, the liver and lungs then became more heavily infected. The large numbers of bacteria found in these tissues by day 8 were mostly localized within a few large abscesses rather than in the multiple small foci of infection usually seen in salmonellosis (14) .
When the challenge inoculum was increased to 103 viable Y. enterocolitica WA, the resulting infection was very uniform so far as the percentage of animals infected and the numbers of bacteria found in the various tissues examined. The number of viable bacteria in the liver and spleen increased quickly and animals began to die 6 days postinfection (Fig. 2) . Infection in the lungs lagged some 2 days behind the liver and spleen but was easily detectable by day 3. Effect of culture temperature on virulence. In the preceding experiments, the challenge inocula were grown at 37 C. Because several differences between Y. enterocolitica WA cultured at 25 and at 37 C had been noted in previous work (4), the influence of temperature on mouse virulence was also studied. A fresh culture of Y. enterocolitica WA grown at 25 C was subcultured into two tubes of broth; one was incubated overnight at 37 C and the other at 25 C. When CD-1 mice were challenged intravenously with the respective cultures, a difference in the in vivo growth behavior over the first 2 h was apparent. The organisms grown at 37 C were cleared from the blood of normal mice very quickly, accumulating primarily in the liver and spleen (Fig. 3) . The viable counts then fell precipitously over the first 2 h. Despite this fact, the surviving bacilli eventually grew rapidly in vivo and reached high counts in the test organs. On the other hand, organisms cultured at 25 C were cleared more slowly from the blood, which was still heavily infected after 2 h (Fig. 4) . The bacterial populations in the liver, lung, and spleen did not decline appreciably after the first few minutes (Fig. 4) , and over the following days the viable counts increased sharply (Fig. 5 ). The growth rates of both the 37 and 25 C grown Y. enterocolitica populations appeared to be about the same once the sys- temic infection had become well established. Thus, except for the initial increase in the rate of phagocytosis and early killing of the 37 C grown organisms, the only difference between the two infections was the consistently higher bacterial count in those animals infected with 25 C grown bacteria. Y. enterocolitica WA cultured at 5 C gave rise to an in vivo growth curve identical to that seen with the 25 C grown cells and was therefore not included in Fig. 4 and 5. The small difference in the size of the respective challenge inocula was not responsible for the difference in the growth curves because the same phenomenon was observed when mice were challenged with the same size inocula or with higher numbers of 37 C grown organisms.
This temperature-related phenomenon was again observed when intraperitoneal clearance and killing was investigated. Although 90% of the opsonized bacteria in both groups were taken up by peritoneal cells over a very short time, negligible killing occurred when bacteria cultured at 25 C were injected, whereas the bacterial counts with the 37 C grown cells decreased 10-fold over a 60-min period (Fig. 6) . (4) . Likewise, the existence of a novel exotoxin or a particularly potent endotoxin in the WA strain could not be demonstrated (P. B. Carter. submitted for publication).
Y. enterocolitica WA is capable of in vitro growth over a broad temperature range (4), but at some point above 27 C, the organism becomes nonmotile, a phenomenon that appears to be characteristic of the Y. enterocolitica group as a whole (16, 18) . The higher cultivation temperatures also result in decreased virulence that correlates with the enhanced inactivation of the challenge inoculum by the normal host. At selected challenge doses, the difference in the virulence of the 25 and 37 C cultures is also expressed in terms of morbidity and mortality. The septicemia resulting from an intravenous inoculum of organisms cultured at 25 C was longer lived than that caused by the 37 C grown organisms, suggesting that the enhanced virulence of the yersiniae cultured at lower temperatures was related to its resistance to phagocytosis. However, peritoneal clearance data indicated that an equal percentage of both the 25 and 37 C grown organisms became cell associated over the 5-min period of phagocytosis, but the 25 C cultured organism then appeared to be more resistant to the intracellular killing. The precise characteristic that is responsible for the increased resistance to in vivo inactivation of the 25 C grown Y. enterocolitica is not known. This finding is very similar to that reported for Y. pestis (3, 5, 10, 11) , and the mechanisms could be the same. A relationship of the in vitro culture temperature to host virulence has been described for other species of Yersinia, but it is interesting to note that the relationship described has been just the inverse of that found for Y. enterocolitica (2) . Such an inversion, allowing for greater virulence at lower temperatures, may account for the predominance of Y. enterocolitica infections in colder climates.
